AELIP

Asociación AELIP

Top of Page
Menu
Español English Deutsch Francaise

2018 Annual ECLip Meeting

2018 ECLip Annual Meeting

April 27-28 2018

MÜNSTER


Klinik für Transplantationsmedizin 

Universitätsklinikum Münster


 Organizer Committee 

Prof. Harmuth Schmidt, Chair (Germany)

Dr. Elena Vorona (Germany)

Prof. Martin Wabitsch (Germany)

Prof. David Araújo-Vilar (Spain)



Final program 

April 27th


15:00

Welcome 

Prof. Harmuth Schmidt, Universitätsklinikum Münster, Germany

15:15

Lipodystrophy proteins in the regulation of fat tissue development and function

Dr Justin Rochford. University of Aberdeen, UK

15:45

FPLD2: what cellular models told us about pathogenesis

Prof. Giovanna Lattanzi, CNR, Unit of Bologna, Italy

16:15

MDPL syndrome: characterization of a cellular model.

Dr. Maria Rosaria D’Apice, Tor Vergata University, Rome, Italy

17:45

Coffee break 

18:15

What do we learn from BSCL2 murine models? Our experience with BSCL2Celia/Celia mouse. 

Prof. David Araujo-Vilar. University of Santiago de Compostela, Spain

18:45

Alterations of immune function and advanced glycation end products in mice with lipodystrophy

Prof. Katrin Hoffmann, Martin-Luther-Universität Halle Wittenberg 

April 28th


08:30

The ECLip patient registry – an update

Prof. Dr. Martin Wabitsch, University of Ulm, Germany 

08:50

ECLip and European Reference Network on Rare Endocrine Conditions

Dr Giovanni Ceccarini. University Hospital of Pisa, Italy

09:10

Inherited and acquired lipodystrophies in Russia: clinical, hormonal and molecular-genetic characteristics

Dr Ekaterina Sorkina. Endocrinology Research Center, Moscow, Russia

09:40

Clinical and molecular characterization of Egyptian patients with lipodystrophy

Prof. Solaf Mohamed Elsayed, Ain Shams University, Cairo, Egypt

10:10

A case series of FPLD2 and FPLD3 with novel mutations: the experience of a single Greek referral center

Prof. Vaia Lambadiari. Medical School Attikon University Hospital, Greece

10:40

Coffee break 

11:15

Lipodystrophy search in Polish patients: Detection of a new PPARG gene (Asp116Gly) mutation in a family.

Prof. Magdalena Szopa, Jagiellonian University Medical College University Hospital, Krakow, Poland 

11:45

Central nervous effects of 12 months of metreleptin substitution in 9 patients with lipodystrophy measured with functional MRI

Dr. Haiko Schlögl. University of Leipzig/University Hospital Leipzig, Germany

12:15

Fontaine syndrome due to SLC25A24 variants  

Dr Karin Writzl, University Medical Centre, Ljubljana, Slovenia 

12:45

MFN2-associated lipomatosis: clinical, metabolic and adipose tissue phenotypes. Prof. Corinne Vigouroux. Centre de Recherche Saint-Antoine, Paris, France

13:15

Acquired lipodystrophies and autoimmunity: our experience and a working proposal for the ECLIP registry groups. 

Prof. Ferruccio Santini/Dr Giovanni Ceccarini. University Hospital of Pisa, Italy

13:45

Lunch

15:00

Barraquer-Simons Type lipodystropghy

Prof. Marie Christine Vantyghem, Centre Hospitalier Universitaire (CHRU) de Lille, France

15:30

Update on therapeutic strategies in Hutchinson-Gilford Progeria and related disorders.

Dr. Karim Harhouri. Hôpital de La Timone - Enfants, Marseille, France

16:00

Nuclear Envelope in Lipodystrophy and Hepatic Steatosis. 

Prof. Howard J. Worman. Columbia University, NY, USA

16:30

Novel treatment studies for familial partial lipodystrophy Syndromes: what is on the horizon? 

Prof. Elif Oral. University of Michigan, USA

17:00

Coffee break 

17:30

Developing Support for Patients with Negative Body Image Due to Lipodystrophy. Claire Adams. University of Cambridge, UK

18:00

International multidisciplinary intervention for lipodystrophy patients since a sociosanitary scope. 

Naca Pérez de Tudela, AELIP, Spain

18:15

Beyond the Metabolics - The Burden of Living with Lipodystrophy from the Patients' Perspective

Andra Stratton, Lipodystrophy United, Albuquerque, New Mexico, USA

18:30

Closing Lecture: Lipodystrophy, an historical perspective. 

Prof. Harmuth Schmidt,, Universitätsklinikum Münster, Germany

19:00

Final conclusions Prof. Harmuth Schmidt,, Universitätsklinikum Münster, Germany



Venue: Factory Hotel

An der Germania Brauerei 5, 48159 Münster, Germany


FREE REGISTRATION


TRAVEL to Meeting  Centre:

By air: 

airport FMO in Münster

https://www.fmo.de/en/


http://www.stadtwerke-muenster.de/privatkunden/busverkehr/fahrplanauskunft/efa/fahrplanauskunft.html


By train: 

The Central Railway Station (Hauptbahnhof - Hbf) of Münster.

https://rail.cc/en/muenster/muenster-central-railway-station/l705


ACCOMODATION: 


Factory Hotel (106 €)

An der Germania Brauerei 5, 48159 Münster, Germany  

(https://www.factoryhotel-muenster.de/?L=2

+49 251 4188 0 | mail@factoryhotel.de


Mövenpick Hotel (128 €)

Kardinal-von-Galen-Ring 65, 48149  Münster, Germany 

(https://www.movenpick.com/en/europe/germany/muenster/hotel-muenster/overview/)

+49 251 8902 0 | hotel.muenster@movenpick.com




Andrea Albers

Sekretariat

Medizinische Klinik B für Gastroenterologie und Hepatologie

Direktor: Univ.-Prof. Dr.med. Hartmut Schmidt

Albert-Schweitzer-Campus 1, Gebäude A14

48149 Münster

Tel.: 0251/83-44826

Fax: 0251/83-48450

Andrea.Albers@ukmuenster.de


 


 
2018 Annual ECLip Meeting
Este sitio web utiliza cookies para facilitar y mejorar la navegación. Si continúas navegando, consideramos que aceptas su uso. POLITICA DE COOKIES